29784.01.01
|
ABRAXANE PD.DIS.INF 5MG/ML VIALx 100MG
|
|
176,18 |
202,51 |
240,42 |
Bristol-Myers Squibb EEIG
|
27334.01.02
|
BARACLUDE F.C.TAB 0,5 MG/TAB BLIST(ALU/ALU)30 x1
|
|
165,87 |
190,66 |
230,39 |
Bristol-Myers Squibb EEIG
|
27334.02.02
|
BARACLUDE F.C.TAB 1 MG/TAB BLIST(ALU/ALU) 30 x1
|
|
167,66 |
192,72 |
232,88 |
Bristol-Myers Squibb EEIG
|
33435.03.02
|
CAMZYOS CAPS 10MG/CAP BT X 28 (2 X 14) CAPS ΣΕ BLISTER (PVC/PCTFE/ALU)
|
|
1.217,30 |
1.353,89 |
1.496,12 |
Bristol-Myers Squibb EEIG
|
33435.04.02
|
CAMZYOS CAPS 15MG/CAP BT X 28 (2 X 14) CAPS ΣΕ BLISTER (PVC/PCTFE/ALU)
|
|
1.217,30 |
1.353,89 |
1.496,12 |
Bristol-Myers Squibb EEIG
|
33435.01.02
|
CAMZYOS CAPS 2,5MG/CAP BT X 28 (2 X 14) CAPS ΣΕ BLISTER (PVC/PCTFE/ALU)
|
|
1.217,30 |
1.353,89 |
1.496,12 |
Bristol-Myers Squibb EEIG
|
33435.02.02
|
CAMZYOS CAPS 5MG/CAP BT X 28 (2 X 14) CAPS ΣΕ BLISTER (PVC/PCTFE/ALU)
|
|
1.217,30 |
1.353,89 |
1.496,12 |
Bristol-Myers Squibb EEIG
|
29892.01.04
|
ELIQUIS F.C.TAB 2,5MG/TAB BTx60 BLISTx1TAB (UNIT DOSE) σε BLISTER (PVC/PVDC/Alu)
|
|
52,31 |
60,13 |
76,49 |
Bristol-Myers Squibb EEIG
|
29892.02.05
|
ELIQUIS F.C.TAB 5MG/TAB BTx100x1δισκίο σε BLISTER (PVC/PVDC/Alu)
|
|
76,78 |
88,25 |
112,25 |
Bristol-Myers Squibb EEIG
|
30589.01.01
|
IMNOVID CAPS 1MG/CAP BTx21 (PVC/PCTFE blister)
|
|
5.464,14 |
6.077,25 |
6.570,73 |
Bristol-Myers Squibb EEIG
|
30589.02.01
|
IMNOVID CAPS 2MG/CAP BTx21 (PVC/PCTFE blister)
|
|
5.620,66 |
6.251,34 |
6.758,95 |
Bristol-Myers Squibb EEIG
|
30589.03.01
|
IMNOVID CAPS 3MG/CAP BTx21 (PVC/PCTFE blister)
|
|
6.057,57 |
6.737,27 |
7.284,34 |
Bristol-Myers Squibb EEIG
|
30589.04.01
|
IMNOVID CAPS 4MG/CAP BTx21 (PVC/PCTFE blister)
|
|
5.613,10 |
6.242,93 |
6.749,86 |
Bristol-Myers Squibb EEIG
|
32666.01.01
|
INREBIC CAPS 100MG/CAP Φιάλη (HDPE) x 120 καψάκια
|
|
3.360,14 |
3.737,17 |
4.040,62 |
Bristol-Myers Squibb EEIG
|
32773.01.01
|
ONUREG F.C.TAB 200MG/TAB BT X 7 ΣΕ BLISTERS (OPA/PVC/ALU)
|
|
5.559,16 |
6.182,93 |
6.684,99 |
Bristol-Myers Squibb EEIG
|
32773.02.01
|
ONUREG F.C.TAB 300MG/TAB BT X 7 ΣΕ BLISTERS (OPA/PVC/ALU)
|
|
5.853,18 |
6.509,95 |
7.038,56 |
Bristol-Myers Squibb EEIG
|
31173.01.02
|
OPDIVO C/S.SOL.IN 10MG/ML BT X 1 VIAL X 10 ML
|
|
905,18 |
1.006,74 |
1.120,50 |
Bristol-Myers Squibb EEIG
|
31173.01.04
|
OPDIVO C/S.SOL.IN 10MG/ML BT X 1 VIAL X 12 ML
|
|
1.108,88 |
1.233,31 |
1.372,68 |
Bristol-Myers Squibb EEIG
|
31173.01.03
|
OPDIVO C/S.SOL.IN 10MG/ML BT X 1 VIAL X 24 ML
|
|
2.181,64 |
2.426,43 |
2.642,75 |
Bristol-Myers Squibb EEIG
|
31173.01.01
|
OPDIVO C/S.SOL.IN 10MG/ML BT X 1 VIAL X 4 ML
|
|
359,73 |
400,09 |
462,27 |
Bristol-Myers Squibb EEIG
|
33192.01.01
|
OPDUALAG C/S.SOL.IN (240+80)MG/VIAL BT X 1 VIAL X 20ML
|
|
5.588,07 |
6.215,09 |
6.719,75 |
Bristol-Myers Squibb EEIG
|
27801.02.05
|
ORENCIA INJ.SOL 125MG/ML BTx4 προγεμισμένες σύριγγες με προστατευτικό βελόνας
|
|
657,04 |
730,75 |
824,95 |
Bristol-Myers Squibb EEIG
|
27801.01.01
|
ORENCIA PD.C.SO.IN 250 MG/VIAL BT x 1 VIAL + 1 σύριγγα
|
|
227,67 |
253,21 |
300,62 |
Bristol-Myers Squibb EEIG
|
32472.01.01
|
REBLOZYL PD.INJ.SOL 25MG/VIAL 1 VIAL
|
|
1.008,99 |
1.122,21 |
1.249,02 |
Bristol-Myers Squibb EEIG
|
32472.02.01
|
REBLOZYL PD.INJ.SOL 75MG/VIAL 1 VIAL
|
|
3.026,63 |
3.366,24 |
3.639,57 |
Bristol-Myers Squibb EEIG
|
27811.02.01
|
REVLIMID CAPS 10 MG/CAP Χάρτινη συσκευασία x 21 (σε BLISTERS PCTFE/PVC/ALU)
|
|
2.448,61 |
2.723,35 |
2.958,92 |
Bristol-Myers Squibb EEIG
|
27811.03.01
|
REVLIMID CAPS 15 MG/CAP Χάρτινη συσκευασία x 21 (σε BLISTERS PCTFE/PVC/ALU)
|
|
2.581,33 |
2.870,97 |
3.111,70 |
Bristol-Myers Squibb EEIG
|
27811.07.01
|
REVLIMID CAPS 20MG/CAP BT x21 (BLIST 3x7) σε BLISTERS (PVC/PCTFE/αλουμίνιο)
|
|
3.267,55 |
3.634,19 |
3.929,28 |
Bristol-Myers Squibb EEIG
|
27811.04.01
|
REVLIMID CAPS 25 MG/CAP Χάρτινη συσκευασία x 21 (σε BLISTERS PCTFE/PVC/ALU)
|
|
3.024,26 |
3.363,60 |
3.636,72 |
Bristol-Myers Squibb EEIG
|
27811.01.01
|
REVLIMID CAPS 5MG/CAP Χάρτινη συσκευασία x 21 (σε BLISTERS PCTFE/PVC/ALU)
|
|
2.505,11 |
2.786,19 |
3.019,81 |
Bristol-Myers Squibb EEIG
|
26580.03.02
|
REYATAZ CAPS 200MG/CAP ΒΤx60 σε BLISTERS (ALU/ALU)
|
|
209,14 |
232,60 |
276,14 |
Bristol-Myers Squibb EEIG
|
26580.05.01
|
REYATAZ CAPS 300MG/CAP Φιάλη (HDPE) x30
|
|
195,47 |
217,40 |
258,10 |
Bristol-Myers Squibb EEIG
|
33399.01.06
|
SOTYKTU F.C.TAB 6MG/TAB BT X 28 (2 Χ 14) ΔΙΣΚΙΑ ΣΕ ΗΜΕΡΟΛΟΓΙΑΚΑ BLISTERS (PVC/PCTFE/ALU)
|
|
575,45 |
640,02 |
725,91 |
Bristol-Myers Squibb EEIG
|
27559.04.01
|
SPRYCEL F.C.TAB 100MG/TAB BTx 30 BOTTLE (HDPE)
|
|
2.112,17 |
2.349,17 |
2.558,60 |
Bristol-Myers Squibb EEIG
|
27559.01.01
|
SPRYCEL F.C.TAB 20mg/TAB BOTTLE (HDPE x 60)
|
|
1.020,64 |
1.135,17 |
1.263,45 |
Bristol-Myers Squibb EEIG
|
27559.02.01
|
SPRYCEL F.C.TAB 50MG/TAB BOTTLE (HDPEx60)
|
|
2.114,23 |
2.351,46 |
2.561,10 |
Bristol-Myers Squibb EEIG
|
27559.03.01
|
SPRYCEL F.C.TAB 70MG/TAB BOTTLE (HDPE x 60)
|
|
2.066,25 |
2.298,10 |
2.502,98 |
Bristol-Myers Squibb EEIG
|
33179.01.01
|
THALIDOMIDE BMS CAPS 50MG/CAP BTx 28 σε BLISTERS PCTFE/PVC
|
|
220,70 |
245,46 |
291,42 |
Bristol-Myers Squibb EEIG
|
28711.01.01
|
VIDAZA PD.INJ.SUS 25MG/ML BTx1 VIAL x 100MG
|
|
193,74 |
215,48 |
255,82 |
Bristol-Myers Squibb EEIG
|
29977.01.02
|
YERVOY C/S.SOL.IN 5MG/ML BTx1VIALx200MGx40ML
|
|
9.953,24 |
11.070,06 |
11.968,95 |
Bristol-Myers Squibb EEIG
|
29977.01.01
|
YERVOY C/S.SOL.IN 5MG/ML BTx1VIALx50MGx10ML
|
|
2.521,21 |
2.804,10 |
3.039,22 |
Bristol-Myers Squibb EEIG
|
32457.01.01
|
ZEPOSIA CAPS 0.46MG/CAP Συσκευασία έναρξης θεραπείας BTx7 καψάκια (4x0.23mg + 3x0.46mg) σε Βlisters PVC/PCTFE/alu
|
|
262,40 |
291,84 |
346,47 |
Bristol-Myers Squibb EEIG
|
32457.02.01
|
ZEPOSIA CAPS 0.92MG/CAP BTx28 καψάκια σε Βlisters PVC/PCTFE/alu
|
|
1.049,56 |
1.167,33 |
1.299,24 |
Bristol-Myers Squibb EEIG
|
22830.04.02
|
ZERIT CAPS 40MG/CAP BTx56(BLIST4x14)
|
|
100,92 |
116,01 |
142,65 |
Bristol-Myers Squibb EEIG
|